Eastern Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Sell |
25,287
-1,157
| -4% | -$41.7K | 0.02% | 196 |
|
|
2025
Q1 | $823K | Sell |
26,444
-28,871
| -52% | -$899K | 0.02% | 219 |
|
|
2024
Q4 | $1.41M | Sell |
55,315
-659
| -1% | -$16.8K | 0.03% | 187 |
|
|
2024
Q3 | $1.58M | Sell |
55,974
-514
| -0.9% | -$14.5K | 0.03% | 194 |
|
|
2024
Q2 | $1.49M | Sell |
56,488
-414
| -0.7% | -$10.9K | 0.06% | 123 |
|
|
2024
Q1 | $1.73M | Sell |
56,902
-8,765
| -13% | -$266K | 0.07% | 120 |
|
|
2023
Q4 | $1.84M | Sell |
65,667
-11,316
| -15% | -$318K | 0.08% | 118 |
|
|
2023
Q3 | $2.09M | Sell |
76,983
-243,177
| -76% | -$6.6M | 0.1% | 114 |
|
|
2023
Q2 | $9.84M | Buy |
320,160
+623
| +0.2% | +$19.2K | 0.47% | 72 |
|
|
2023
Q1 | $11.5M | Buy |
319,537
+86,238
| +37% | +$3.11M | 0.58% | 69 |
|
|
2022
Q4 | $9.22M | Buy |
+233,299
| New | +$9.22M | 0.49% | 66 |
|